Skip to main content
logo
ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.330
-0.110 (-7.64%)
At close: Jun 5, 2026, 4:00 PM EDT
1.300
-0.030 (-2.26%)
After-hours: Jun 5, 2026, 6:47 PM EDT

ABVC BioPharma Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
33.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024509.59K357.16K234.31%
Dec 31, 2023152.43K-817.35K-84.28%
Dec 31, 2022969.78K613.99K172.57%
Dec 31, 2021355.80K-127.25K-26.34%
Dec 31, 2020483.05K-218.67K-31.16%
Dec 31, 2019701.72K694.76K9,987.97%
Dec 31, 20186.96K--
Dec 31, 2017---
Dec 31, 2016988.15K--
Sep 30, 2016---
Sep 30, 20153.36K-4.43K-56.85%
Sep 30, 20137.79K2.07K36.28%
Sep 30, 20125.71K2.52K79.12%
Sep 30, 20113.19K-11.67K-78.53%
Sep 30, 201014.86K--
Sep 30, 2009---
Sep 30, 200825.09K-16.58K-39.78%
Sep 30, 200741.67K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evaxion7.53M
Plus Therapeutics5.21M
Aligos Therapeutics4.71M
Daré Bioscience1.16M
Actinium Pharmaceuticals90.00K
INmune Bio50.00K
Revenue Rankings

ABVC News

More News